News
BioCMOS
- Tuesday, 11 December 2018
The new frontier in smart and efficient diagnostics and analytics is represented by the fusion of semiconductor technologies and electrochemical sensors. BioCMOS devices, also known as Lab-on-CMOS or CMOS biosensors, consist of microelectronic interfaces with integrated high-density sensing elements. On top of these elements, biological and chemical assays can be directly performed, limiting considerably the need for additional external units. The Bioelectronics group is currently developing BioCMOS microsystems that target applications, including lab-on-chip and organ-on-chip platforms, point-of-care devices, implantable and injectable smart biosensors. By leveraging the distinctive features of modern complementary metal-oxide semiconductor (CMOS) technology, we can develop complex yet compact microelectronic bio-devices capable of interacting with biological networks at a cellular and molecular scale with unprecedented resolution and sensitivity. BioCMOS technology promises to play a key role in defining future targeted therapies and personalized medicine, cost-effective drug discovery and development, and efficient disease management strategies. Read more on Page 18-21.
News
Best Paper Award at EuCAP 2024
Best Antenna Theory Paper Award for Caspar Coco Martin, Weiya Hu, and Daniele Cavallo
NWO M2 grant awarded to Francesco Fioranelli
STOI incorporated in Matlab
STOI is a widely used measure for "short-time objective intelligibility" in (compressed) speech, and was developed by members of the SPS group
Microchips in a connected world
Discover in this video how microelectronics is bridging connections worldwide while tackling the energy transition.
At last, a woman’s name on the nameplate
For the first time, one of the spaces in the EEMCS Faculty bears the name of a woman. It is Johanna Manders, one of the first women to graduate in Electrical Engineering. ‘If the name attracts just one young women to come and study here, the goal has been achieved.’